Abstract:Computational drug discovery methods have been used in this study to identify potential inhibitors for Pantothenate Synthetase, a crucial enzyme for mycobacterial survival. Four compounds, CID2813602, 24357538, CID753354, and CID4798023, have shown strong binding energies and stable interactions with the target protein. These compounds hold promise for the development of new treatments targeting drug‐resistant TB strains. Antibiotics have played a crucial role in significantly reducing the incidence of tuberculosis (TB) infection worldwide. Even before the mid‐20th century, the mortality rate of TB onset within five years was around 50 %. So, the introduction of antibiotics has changed the scenario of TB from a serious threat to a manageable one. However, the emergence of resistance to anti‐TB drugs poses a significant challenge. So, to overcome this situation the therapeutic approaches and drug targets need to be reformed. This study focused on finding potential inhibitors by targeting Pantothenate Synthetase, a crucial enzyme for Mycobacterium tuberculosis (Mtb) survival, through computational drug discovery methods. Molecular docking and virtual screening were employed to identify potential inhibitors from Diverse‐lib. Four compounds, namely CID2813602, 24357538, CID753354, and CID4798023, exhibited strong binding energies and stable interaction with the target protein. Further assessment of these compounds through MD simulation and Post MD simulation showed significant dynamic stability. The minimum energy transition calculated using the free energy landscape analysis of these compounds when docked with Pantothenate Synthetase confirmed the stability of each complex due to its minimum energy production. The free binding energy calculation of each complex also showed the intramolecular interaction contributes to the strong binding affinity of the compounds within the enzyme's active site clarifying their mechanisms of action. This research showcases the effectiveness of computational methods in promptly identifying potential anti‐TB drugs, paving the way for future experimental validation and optimization. It holds promise for the development of new treatments targeting drug‐resistant TB strains.

Effects of a New Anti-Tuberculosis Compound,s28,on the Expression of Mycobacterium Tuberculosis Proteome

Comparative Proteomic and Phosphoproteomic Analysis of Mycobacteria Treated with Flavonoid Quercetin and Non-Flavonoid Caffeic Acid

Identification of protein targets of compound HY-152E with anti-tuberculosis activity using drug affinity responsive target stability technique

Comparison of the Proteome of Mycobacterium Tuberculosis Cytosolic Basic Proteins Betwen Multiple Drugresistant Stainn and Sensitive Stains

Identification of antituberculosis agents that target ribosomal protein interactions using a yeast two-hybrid system

Comparison of the Proteome of Isoniazid-Resistant and -Susceptible Strains Ofmycobacterium Tuberculosis

The Inhibition of Folylpolyglutamate Synthetase (folc) in the Prevention of Drug Resistance in Mycobacterium Tuberculosis by Traditional Chinese Medicine.

[Effects of the Radix Ranuncoli Ternati Extracts on Mycobacterium Tuberculosis Proteome Profiling Revealed by 2D Electrophoresis].

Synthesis and Evaluation of (S,S)-N,N '-Bis-[3-(2,2 ',6,6 '-Tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) Analogs with Anti-Tuberculosis Activity

Comparison of the Proteome of Mycobacterium Tuberculosis Isoniazid Susceptible Strain with Isoniazid Resistant Strain

An Extensive Computational Investigation of Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors from Diverse‐Lib Compounds Library

Comprehensive Proteomic Profiling of the Membrane Constituents of a Mycobacterium Tuberculosis Strain.

Identification of Differential Expression Proteins of Mycobacterium Tuberculosis Strain Isolated from Clinical Species Treated with Radix Ranuncoli Ternati Extracts by Comparative Proteomics

Integrating computational and experimental approaches in discovery and validation of MmpL3 pore domain inhibitors for specific labelling of Mycobacterium tuberculosis

A Two-Way Proteome Microarray Strategy to Identify Novel Mycobacterium tuberculosis -Human Interactors.

Mycobacterium tuberculosis proteome microarray for global studies of protein function and immunogenicity

Deletion of the Mycobacterium tuberculosis cyp138 gene leads to changes in membrane-related lipid composition and antibiotic susceptibility

Application of Proteomics in the Study of Mycobacterium tuberculosis

Analysis of Differential Expression Proteins of U937 Infected with Isoniazid-resistant MTB by Two-dimensional Electrophoresis

Identification of Novel Antimicrobial Compounds Targeting Mycobacterium tuberculosis S-Adenosyl-L-Homocysteine Hydrolase Using Dual Hierarchical In Silico Structure-Based Drug Screening

Proteomic Analysis of Sputum in Patients with Active Pulmonary Tuberculosis